Kezar Life Sciences (KZR) Return on Assets (2021 - 2025)

Kezar Life Sciences' Return on Assets history spans 5 years, with the latest figure at 0.58% for Q1 2025.

  • For Q1 2025, Return on Assets fell 10.0% year-over-year to 0.58%; the TTM value through Mar 2025 reached 0.58%, down 10.0%, while the annual FY2024 figure was 0.46%, 7.0% down from the prior year.
  • Return on Assets for Q1 2025 was 0.58% at Kezar Life Sciences, down from 0.54% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.21% in Q3 2022 and bottomed at 0.58% in Q1 2025.
  • The 5-year median for Return on Assets is 0.33% (2021), against an average of 0.37%.
  • The largest annual shift saw Return on Assets increased 9bps in 2022 before it decreased -23bps in 2024.
  • A 5-year view of Return on Assets shows it stood at 0.31% in 2021, then rose by 28bps to 0.23% in 2022, then plummeted by -92bps to 0.43% in 2023, then dropped by -25bps to 0.54% in 2024, then decreased by -7bps to 0.58% in 2025.
  • Per Business Quant, the three most recent readings for KZR's Return on Assets are 0.58% (Q1 2025), 0.54% (Q4 2024), and 0.56% (Q3 2024).